U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT06926621) titled 'A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I' on April 10.
Brief Summary: The purpose of the study is to evaluate the long-term safety and tolerability, efficacy and pharmacokinetics of VX-670 in participants with Myotonic Dystrophy Type I (DM1).
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
Myotonic Dystrophy Type 1 (DM1)
Intervention:
DRUG: VX-670
Solution for intravenous administration.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Vertex Pharmaceuticals Incorporated
Published by HT Digital Content Services with permission from Health Daily Diges...